Literature DB >> 14519806

Coenzyme Q intake elevates the mitochondrial and tissue levels of Coenzyme Q and alpha-tocopherol in young mice.

Sergey Kamzalov1, Nathalie Sumien, Michael J Forster, Rajindar S Sohal.   

Abstract

The main objective of this study was to resolve the issue of whether the amounts of Coenzyme Q (CoQ), which is endogenously synthesized in cells, can be elevated in tissues and mitochondria of young mice by dietary supplementation with CoQ10. The prevalent view is that the uptake of exogenous CoQ by tissues other than plasma and liver either does not occur or is quite minimal. Mice, 6 mo of age, were fed 0, 148 or 654 mg CoQ10/(kg body x d) in their diets for 11 wk. CoQ10 intake enhanced both CoQ9 and CoQ10 homologues in the plasma, and in homogenates and mitochondria of liver, heart and skeletal muscle. CoQ was elevated in brain mitochondria, but not in the brain homogenate. The uptake of exogenous CoQ was higher in mitochondria of heart and skeletal muscle than those in liver. CoQ10 administration also elevated the alpha-tocopherol concentration in tissue homogenates and their mitochondria, thereby providing an in vivo indication of the "sparing" effect of CoQ on alpha-tocopherol. Results of this study demonstrate that, contrary to the historical view, both total and mitochondrial CoQ concentrations in the heart and skeletal muscle and in the mitochondria of brain of young mice can be augmented by dietary supplementation. Furthermore, CoQ intake enhances the antioxidative potential of tissues by elevating the endogenous amounts of alpha-tocopherol.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14519806     DOI: 10.1093/jn/133.10.3175

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  24 in total

1.  Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease.

Authors:  Miriam A Hickey; Chunni Zhu; Vera Medvedeva; Nicholas R Franich; Michael S Levine; Marie-Françoise Chesselet
Journal:  Mol Cell Neurosci       Date:  2011-10-20       Impact factor: 4.314

2.  Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease.

Authors:  Magali Dumont; Khatuna Kipiani; Fangmin Yu; Elizabeth Wille; Maya Katz; Noel Y Calingasan; Gunnar K Gouras; Michael T Lin; M Flint Beal
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

3.  Effect of coenzyme Q10 intake on endogenous coenzyme Q content, mitochondrial electron transport chain, antioxidative defenses, and life span of mice.

Authors:  Rajindar S Sohal; Sergey Kamzalov; Nathalie Sumien; Melissa Ferguson; Igor Rebrin; Kevin R Heinrich; Michael J Forster
Journal:  Free Radic Biol Med       Date:  2005-11-09       Impact factor: 7.376

4.  A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy.

Authors:  Beth A Taylor; Lindsay Lorson; C Michael White; Paul D Thompson
Journal:  Atherosclerosis       Date:  2014-12-17       Impact factor: 5.162

5.  Evaluation of coenzyme Q as an antioxidant strategy for Alzheimer's disease.

Authors:  Teri L Wadsworth; James A Bishop; Anuradha S Pappu; Randall L Woltjer; Joseph F Quinn
Journal:  J Alzheimers Dis       Date:  2008-06       Impact factor: 4.472

6.  Association between Crohn's disease and AarF domain-containing kinase 4 glomerulopathy.

Authors:  Toshihiko Kakiuchi; Yasufumi Ohtsuka; Tadashi Sato; Aiko Nakayama; Kumiko Jinnouchi; Masafumi Oka; Muneaki Matsuo
Journal:  Clin J Gastroenterol       Date:  2019-01-31

7.  Comprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocycline.

Authors:  Liliana B Menalled; Monica Patry; Natalie Ragland; Phillip A S Lowden; Jennifer Goodman; Jennie Minnich; Benjamin Zahasky; Larry Park; Janet Leeds; David Howland; Ethan Signer; Allan J Tobin; Daniela Brunner
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

Review 8.  Coenzyme Q, oxidative stress and aging.

Authors:  Rajindar S Sohal; Michael J Forster
Journal:  Mitochondrion       Date:  2007-03-30       Impact factor: 4.160

Review 9.  Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.

Authors:  Gerwyn Morris; George Anderson; Michael Berk; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-06-13       Impact factor: 5.590

10.  Coenzyme Q10 enhances remyelination and regulate inflammation effects of cuprizone in corpus callosum of chronic model of multiple sclerosis.

Authors:  Behnam Khalilian; Soheila Madadi; Nima Fattahi; Beheshteh Abouhamzeh
Journal:  J Mol Histol       Date:  2020-11-27       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.